As a cornerstone of the foundation strategic plan and mission, the National Psoriasis Foundation (NPF) strives to lead collaborative, transformational research in psoriatic disease and increase the lifespan and health of individuals living with psoriatic disease. On September 10, 2021, NPF will be hosting the 2021 NPF Research Symposium: The Future of Psoriatic Disease - Improving Health Outcomes, to strengthen and support medical and research endeavors towards prevention, precision medicine, comorbidities, equity for underrepresented populations, and a cure, by providing a venue for education, dissemination of scientific results, and collaboration that is specific to psoriatic disease.
This NPF Research Symposium, which is held every 2 years, provides a unique opportunity for experts across disciplines to come together to discuss and advance research and medical standard of care in the field for psoriatic disease. The Keynote Address will be given by Dr. Michelle McMurry-Heath, president and CEO of Biotechnology Innovation Organization (BIO).
When asked why a patient advocacy organization focused on psoriatic disease would invite Dr. McMurry-Heath to be the keynote speaker at the upcoming research symposium, the answer was easy for NPF Chief Scientific and Medical Officer Stacie Bell, Ph.D. “Our organizations have a shared vision of evidence-based medicine, access to care, and supporting policies for improved health outcomes for our communities,” says Dr. Bell. “BIO has a storied history of advocacy and has played a huge role in shaping scientific advances from multiple perspectives.”
That statement that is supported by evidence of the work they do and the leadership of Dr. McMurry-Heath. “NPF and BIO are both organizations trying to push the envelope to improve lives,” says Dr. Bell. “I am thrilled to have Dr. McMurry-Heath join the symposium to inspire our researchers to continue to elevate our efforts for our community.”